Amgen has appointed Jonathan M Peacock to the role of chief financial officer (CFO) with effect from September 1, 2010. He will take over the role from Michael A Kelly, who has served as acting CFO since May 2010. Peacock will have responsibility for Amgen's finance and investor relations operations, and will report to Amgen's chairman and CEO, Kevin W Sharer.<br />Peacock will join from Novartis, where he has held the role of CFO and administration officer since 2005, leading the finance, information technology, purchasing, strategic planning and mergers and acquisitions functions.<br />Speaking about the appointment, Sharer said: "I am delighted to have a leader of Jonathan's talent, vision and international experience join Amgen at a time when we are expanding globally."